BRCA2 and cancer: Our results on BRCA2 cancers were quite similar to those of Palacios and colleagues [18] and Lakhani and colleagues [17], although in the former study the BRCA2 cancers were more ER-positive and PgR-positive (on the basis of smaller sample set of 14 cases).